252 related articles for article (PubMed ID: 24498098)
1. Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease.
Kaku Y; Imaoka H; Morimatsu Y; Komohara Y; Ohnishi K; Oda H; Takenaka S; Matsuoka M; Kawayama T; Takeya M; Hoshino T
PLoS One; 2014; 9(1):e87400. PubMed ID: 24498098
[TBL] [Abstract][Full Text] [Related]
2. Effects of corticosteroids on COPD lung macrophage phenotype and function.
Higham A; Scott T; Li J; Gaskell R; Dikwa AB; Shah R; Montero-Fernandez MA; Lea S; Singh D
Clin Sci (Lond); 2020 Apr; 134(7):751-763. PubMed ID: 32227160
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and potential role of M2 macrophages in COPD.
He S; Xie L; Lu J; Sun S
Int J Chron Obstruct Pulmon Dis; 2017; 12():3029-3039. PubMed ID: 29089751
[TBL] [Abstract][Full Text] [Related]
4. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
Soldano S; Pizzorni C; Paolino S; Trombetta AC; Montagna P; Brizzolara R; Ruaro B; Sulli A; Cutolo M
PLoS One; 2016; 11(11):e0166433. PubMed ID: 27846260
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease.
Nielsen MC; Andersen MN; Grønbæk H; Damgaard Sandahl T; Møller HJ
Scand J Gastroenterol; 2020 May; 55(5):588-596. PubMed ID: 32393080
[No Abstract] [Full Text] [Related]
6. Expression of CD206 and CD163 on intermediate CD14
Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
[TBL] [Abstract][Full Text] [Related]
7. CD206
Haque ASMR; Moriyama M; Kubota K; Ishiguro N; Sakamoto M; Chinju A; Mochizuki K; Sakamoto T; Kaneko N; Munemura R; Maehara T; Tanaka A; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
Sci Rep; 2019 Oct; 9(1):14611. PubMed ID: 31601953
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the CD163-Haptoglobin Axis in the Airways of COPD Patients.
Higham A; Baker JM; Jackson N; Shah R; Lea S; Singh D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011566
[TBL] [Abstract][Full Text] [Related]
9. Antibody combinations for optimized staining of macrophages in human lung tumours.
Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
[TBL] [Abstract][Full Text] [Related]
10. Localization of Macrophages in the Human Lung via Design-based Stereology.
Hume PS; Gibbings SL; Jakubzick CV; Tuder RM; Curran-Everett D; Henson PM; Smith BJ; Janssen WJ
Am J Respir Crit Care Med; 2020 May; 201(10):1209-1217. PubMed ID: 32197050
[No Abstract] [Full Text] [Related]
11. S100A9/CD163 Expression in Circulating Classical Monocytes in Chronic Obstructive Pulmonary Disease.
Yamashita M; Utsumi Y; Yamauchi K
COPD; 2020 Oct; 17(5):587-594. PubMed ID: 32962431
[TBL] [Abstract][Full Text] [Related]
12. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
[TBL] [Abstract][Full Text] [Related]
13. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.
Chana KK; Fenwick PS; Nicholson AG; Barnes PJ; Donnelly LE
J Allergy Clin Immunol; 2014 Jan; 133(1):207-16.e1-11. PubMed ID: 24176116
[TBL] [Abstract][Full Text] [Related]
14. CD163 and CD206 expression does not correlate with tolerance and cytokine production in LPS-tolerant human monocytes.
Alves-Januzzi AB; Brunialti MKC; Salomao R
Cytometry B Clin Cytom; 2017 May; 92(3):192-199. PubMed ID: 26352275
[TBL] [Abstract][Full Text] [Related]
15. Appearance of remodelled and dendritic cell-rich alveolar-lymphoid interfaces provides a structural basis for increased alveolar antigen uptake in chronic obstructive pulmonary disease.
Mori M; Andersson CK; Svedberg KA; Glader P; Bergqvist A; Shikhagaie M; Löfdahl CG; Erjefält JS
Thorax; 2013 Jun; 68(6):521-31. PubMed ID: 23412435
[TBL] [Abstract][Full Text] [Related]
16. Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity.
Bazzan E; Turato G; Tinè M; Radu CM; Balestro E; Rigobello C; Biondini D; Schiavon M; Lunardi F; Baraldo S; Rea F; Simioni P; Calabrese F; Saetta M; Cosio MG
Respir Res; 2017 Feb; 18(1):40. PubMed ID: 28231829
[TBL] [Abstract][Full Text] [Related]
17. Triggering Receptor Expressed on Myeloid Cells-2 Expression Tracks With M2-Like Macrophage Activity and Disease Severity in COPD.
Byers DE; Wu K; Dang-Vu G; Jin X; Agapov E; Zhang X; Battaile JT; Schechtman K; Yusen R; Pierce RA; Holtzman MJ
Chest; 2018 Jan; 153(1):77-86. PubMed ID: 29017955
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of a phagocytic receptor Siglec-1 on alveolar macrophages in chronic obstructive pulmonary disease.
Tanno A; Fujino N; Yamada M; Sugiura H; Hirano T; Tanaka R; Sano H; Suzuki S; Okada Y; Ichinose M
Respir Res; 2020 Jan; 21(1):30. PubMed ID: 31992280
[TBL] [Abstract][Full Text] [Related]
19. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.
Létuvé S; Kozhich A; Arouche N; Grandsaigne M; Reed J; Dombret MC; Kiener PA; Aubier M; Coyle AJ; Pretolani M
J Immunol; 2008 Oct; 181(7):5167-73. PubMed ID: 18802121
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.
Heftdal LD; Loft AG; Hendricks O; Ashouri Christiansen A; Schiøttz-Christensen B; Arnbak B; Jurik AG; Østgård R; Winding Deleuran B; Møller HJ; Greisen SR
Scand J Clin Lab Invest; 2018 Oct; 78(6):483-489. PubMed ID: 30176763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
